Chronic nephritic syndrome with diffuse crescentic glomerulonephritis
ICD-10 N03.7 is a billable code used to indicate a diagnosis of chronic nephritic syndrome with diffuse crescentic glomerulonephritis.
Chronic nephritic syndrome with diffuse crescentic glomerulonephritis is characterized by the presence of significant renal impairment due to the inflammation of the glomeruli, leading to the formation of crescents in the Bowman’s space. This condition typically presents with symptoms such as hematuria, proteinuria, and hypertension. Patients may also experience edema and renal insufficiency. The crescentic formation indicates a severe form of glomerulonephritis, often associated with rapidly progressive renal failure. Diagnosis is confirmed through renal biopsy, which reveals crescentic changes along with inflammatory cell infiltration. Management involves immunosuppressive therapy, including corticosteroids and cytotoxic agents, to reduce inflammation and prevent further renal damage. Close monitoring of renal function and regular follow-up are essential to manage complications and adjust treatment as necessary.
Comprehensive documentation of clinical findings, laboratory results, and treatment plans.
Patients presenting with hematuria, proteinuria, and renal insufficiency.
Ensure all relevant lab results and imaging studies are included in the documentation.
Detailed pathology reports from renal biopsies, including histological findings.
Biopsy evaluations for suspected glomerulonephritis.
Pathology reports should clearly indicate the presence of crescents and other relevant findings.
Used when a renal biopsy is performed to confirm diagnosis.
Pathology report and clinical notes supporting the need for biopsy.
Nephrology specialists should ensure that the biopsy results are clearly documented.
Key symptoms include hematuria, proteinuria, hypertension, and edema. Patients may also experience fatigue and renal insufficiency.
